LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Available-for-sale
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Debt Securities, Available-for-sale of $351.06 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale $351.06M.
- 2026-03-31: Debt Securities, Available-for-sale $664.33M.
- 2025-12-31: Debt Securities, Available-for-sale $558.59M.
- 2025-09-30: Debt Securities, Available-for-sale $525.15M.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2026-06-30 | $351.06M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $664.33M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $558.59M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $525.15M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $150.85M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $136.76M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $183.86M 10-K · filed 2026-02-27 | $143.62M 10-K · filed 2025-02-28 |
| 2024-09-30 | $92.71M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $155.78M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $178.50M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $115.17M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $146.55M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $154.46M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $134.58M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $103.74M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $99.03M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $123.25M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $168.86M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $290.70M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $257.61M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $239.75M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $262.99M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $324.48M 10-Q · filed 2021-11-09 | |
| 2018-09-30 | $891.13M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $805.47M 10-Q · filed 2018-08-08 | |
| 2017-12-31 | $181.04M 10-Q · filed 2018-11-08 | |
| 2015-03-31 | $12.06M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $8.39M 10-Q · filed 2015-05-11 | $5.68M 10-K · filed 2014-12-01 |
| 2014-09-30 | $7.19M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $8.75M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $13.62M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $5.68M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $4.97M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $4.16M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $3.93M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $2.77M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $1.34M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.84M 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $11.34M 10-Q · filed 2012-11-14 |